Roth Affirms TG Therapeutics (TGTX) at 'Focus Pick'; Sees Strong Results in 2016

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/6/2026

1. KRG
2. SPY
3. ALAR
4. EXC
5. SKA-B
6. PBA
7. CCH:LN
8. META
9. BAJAJHFL:I
10. CCHGY

Go back to Roth Affirms TG Therapeutics (TGTX) at 'Focus Pick'; Sees Strong Results in 2016

TG Therapeutics (TGTX) Reports Q4 Loss of $0.37/Share

March 7, 2016 4:03 PM EST

TG Therapeutics (NASDAQ: TGTX) reported Q4 EPS of ($0.37), versus ($0.48) reported last year. Revenue for the quarter came in at $38.1 million, versus $38.1 million reported last year.

For earnings history and earnings-related data on TG Therapeutics (TGTX) click here.

... More